Our Technology

EMTensor has developed electromagnetic brain imaging technology that falls within the category of medical imaging devices, such as MRI, CT, PET, and ultrasound. The underlying technology of our brain scanning device is a novel medical imaging modality—electromagnetic (microwave) tomography—which has not been previously applied in clinical medical imaging practice. This groundbreaking technology is now considered a technology breakthrough by many medical professionals worldwide.

The fundamentals of microwave tomography are under development by many scientific groups, institutions, and start-up companies and have robust scientific and clinical validation.

The current EMTensor BrainScanner is the fourth generation of prototypes and the first commercial product, which was presented at RSNA 2018.

EMTensor Brain Scanner A

Model for ambulances.
Not yet FDA cleared or CE marked.

EMTensor Brain Scanner H

Model for in-hospital settings.
Presented at the RSNA booth. Not yet FDA cleared or CE marked.

EMTensor Brain Scanner H-FN

EMTensor BrainScanner H modified version for functional neuroimaging.
Not yet FDA cleared or CE marked.

First Intended Use

EMTensor BrainScanner’s first intended use for receiving marketing approval by the USA Food and Drug Administration (FDA clearance) and European Commission (CE marking):

Rapid screening of the brain in adults to provide information allowing clinicians to assess and monitor disorders caused by impaired cerebral circulation, such as hemorrhagic or ischemic strokes.

The EMTensor Brain Scanner can also be used as an adjunct to other standard imaging methodologies and clinical assessment.

EMTensor brain scanner products are currently under clinical investigation. They are NOT available for sale in the USA or worldwide.

Electromagnetic tomography uses nonionizing electromagnetic radiation to differentiate between human tissues. Using a unique antenna design, a complex electromagnetic field is created that interacts with a biological object. This interaction changes the electromagnetic field, which is further measured by sensors and analyzed by a set of sophisticated, proprietary algorithms.

Differences in the dielectric properties of various tissues enable the detection of functional and pathological conditions, including (but not limited to) tissue blood content or flow, hypoxia, ischemia, and infarction, facilitating the identification of strokes and traumatic brain injuries.

The EMTensor technology roadmap envisages further miniaturization of the scanning device and development of its own system-on-chip. We anticipate that the cost of materials will decrease dramatically over the next 3 years.

The technology roadmap and research and development team will support EMTensor’s clinical applications roadmap, which is planned in detail for the next 3 years.

During the past 7 years, EMTensor has developed four generations of brain scanning prototypes, with non-incremental improvements in each generation. The duration of each prototype development cycle is approximately 1.5 years.



File File size
pdf EMTensor G4 2 MB